a novel airway device for for diagnostic trans esophageal echocardiography in pediatrics

Phase 3

• Conditions: Paediatrics; Cardiology; Anaesthesia

• Registration Number: PACTR202008749509618
• Lead Sponsor: Dr. Mona Raafat Elghamry

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-31
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

One hundred and forty patients eligible for elective interventional TEE in the cardiac lab.
aged 8-18 years old,
ASA II and III
weighed = 30 kg

Exclusion Criteria

predicted difficult airway,
known cervical spine disease,
neurodevelopmental delay,
patients with risk of aspiration or any contraindication to supraglottic airway device insertion,
those requiring TEE for complex intervention (e.g. heart surgery, interventional procedures >60 min), hemodynamically unstable patients,
those who need ventilatory support.

Study & Design

• Study Type: Interventional
• Study Design: Not specified